Stryker Corporation (SYK) - Net Assets
Based on the latest financial reports, Stryker Corporation (SYK) has net assets worth $22.42 Billion USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($47.84 Billion) and total liabilities ($25.42 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check SYK asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $22.42 Billion |
| % of Total Assets | 46.86% |
| Annual Growth Rate | 16.58% |
| 5-Year Change | 50.7% |
| 10-Year Change | 134.76% |
| Growth Volatility | 13.25 |
Stryker Corporation - Net Assets Trend (1985–2025)
This chart illustrates how Stryker Corporation's net assets have evolved over time, based on quarterly financial data. Also explore total assets of Stryker Corporation for the complete picture of this company's asset base.
Annual Net Assets for Stryker Corporation (1985–2025)
The table below shows the annual net assets of Stryker Corporation from 1985 to 2025. For live valuation and market cap data, see how much is Stryker Corporation worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $22.42 Billion | +8.66% |
| 2024-12-31 | $20.63 Billion | +10.98% |
| 2023-12-31 | $18.59 Billion | +11.90% |
| 2022-12-31 | $16.62 Billion | +11.69% |
| 2021-12-31 | $14.88 Billion | +13.70% |
| 2020-12-31 | $13.08 Billion | +2.16% |
| 2019-12-31 | $12.81 Billion | +9.18% |
| 2018-12-31 | $11.73 Billion | +17.37% |
| 2017-12-31 | $9.99 Billion | +4.65% |
| 2016-12-31 | $9.55 Billion | +12.21% |
| 2015-12-31 | $8.51 Billion | -0.99% |
| 2014-12-31 | $8.60 Billion | -4.99% |
| 2013-12-31 | $9.05 Billion | +5.23% |
| 2012-12-31 | $8.60 Billion | +11.90% |
| 2011-12-31 | $7.68 Billion | +7.10% |
| 2010-12-31 | $7.17 Billion | +8.77% |
| 2009-12-31 | $6.60 Billion | +21.98% |
| 2008-12-31 | $5.41 Billion | +0.52% |
| 2007-12-31 | $5.38 Billion | +28.33% |
| 2006-12-31 | $4.19 Billion | +28.88% |
| 2005-12-31 | $3.25 Billion | +16.53% |
| 2004-12-31 | $2.79 Billion | +29.51% |
| 2003-12-31 | $2.15 Billion | +43.83% |
| 2002-12-31 | $1.50 Billion | +41.85% |
| 2001-12-31 | $1.06 Billion | +23.55% |
| 2000-12-31 | $854.90 Million | +27.31% |
| 1999-12-31 | $671.50 Million | +0.40% |
| 1998-12-31 | $668.80 Million | +3.13% |
| 1997-12-31 | $648.50 Million | +5.22% |
| 1996-12-31 | $616.30 Million | +10.19% |
| 1995-12-31 | $559.30 Million | +22.04% |
| 1994-12-31 | $458.30 Million | +58.91% |
| 1993-12-31 | $288.40 Million | +24.15% |
| 1992-12-31 | $232.30 Million | +29.13% |
| 1991-12-31 | $179.90 Million | +21.64% |
| 1990-12-31 | $147.90 Million | +32.05% |
| 1989-12-31 | $112.00 Million | +23.08% |
| 1988-12-31 | $91.00 Million | +21.01% |
| 1987-12-31 | $75.20 Million | +25.96% |
| 1986-12-31 | $59.70 Million | +23.09% |
| 1985-12-31 | $48.50 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Stryker Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 46427.3% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $20.47 Billion | 91.31% |
| Common Stock | $38.00 Million | 0.17% |
| Other Components | $1.91 Billion | 8.52% |
| Total Equity | $22.42 Billion | 100.00% |
Stryker Corporation Competitors by Market Cap
The table below lists competitors of Stryker Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
UNICREDIT S.P.A. ADR
F:CRIP
|
$112.81 Billion |
|
Altria Group
NYSE:MO
|
$112.89 Billion |
|
Capital One Financial Corporation
NYSE:COF
|
$114.98 Billion |
|
China Merchants Bank Co Ltd
SHG:600036
|
$115.52 Billion |
|
Corning Incorporated
NYSE:GLW
|
$112.74 Billion |
|
China Life Insurance Co Ltd A
SHG:601628
|
$111.74 Billion |
|
FAST RETAIL.CO.SP.HDR 1
F:FR7H
|
$111.69 Billion |
|
Parker-Hannifin Corporation
NYSE:PH
|
$111.35 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Stryker Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 20,634,000,000 to 22,420,000,000, a change of 1,786,000,000 (8.7%).
- Net income of 3,246,000,000 contributed positively to equity growth.
- Dividend payments of 1,284,000,000 reduced retained earnings.
- Other comprehensive income increased equity by 293,000,000.
- Other factors decreased equity by 469,000,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $3.25 Billion | +14.48% |
| Dividends Paid | $1.28 Billion | -5.73% |
| Other Comprehensive Income | $293.00 Million | +1.31% |
| Other Changes | $-469.00 Million | -2.09% |
| Total Change | $- | 8.66% |
Book Value vs Market Value Analysis
This analysis compares Stryker Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 5.02x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 2041.84x to 5.02x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1985-12-31 | $0.14 | $294.73 | x |
| 1986-12-31 | $0.18 | $294.73 | x |
| 1987-12-31 | $0.21 | $294.73 | x |
| 1988-12-31 | $0.26 | $294.73 | x |
| 1989-12-31 | $0.29 | $294.73 | x |
| 1990-12-31 | $0.41 | $294.73 | x |
| 1991-12-31 | $0.46 | $294.73 | x |
| 1992-12-31 | $0.61 | $294.73 | x |
| 1993-12-31 | $0.74 | $294.73 | x |
| 1994-12-31 | $0.93 | $294.73 | x |
| 1995-12-31 | $1.17 | $294.73 | x |
| 1996-12-31 | $1.35 | $294.73 | x |
| 1997-12-31 | $1.57 | $294.73 | x |
| 1998-12-31 | $1.66 | $294.73 | x |
| 1999-12-31 | $1.73 | $294.73 | x |
| 2000-12-31 | $2.13 | $294.73 | x |
| 2001-12-31 | $2.65 | $294.73 | x |
| 2002-12-31 | $3.51 | $294.73 | x |
| 2003-12-31 | $5.08 | $294.73 | x |
| 2004-12-31 | $6.72 | $294.73 | x |
| 2005-12-31 | $8.03 | $294.73 | x |
| 2006-12-31 | $10.19 | $294.73 | x |
| 2007-12-31 | $12.89 | $294.73 | x |
| 2008-12-31 | $13.07 | $294.73 | x |
| 2009-12-31 | $16.51 | $294.73 | x |
| 2010-12-31 | $17.96 | $294.73 | x |
| 2011-12-31 | $19.73 | $294.73 | x |
| 2012-12-31 | $22.45 | $294.73 | x |
| 2013-12-31 | $23.68 | $294.73 | x |
| 2014-12-31 | $22.46 | $294.73 | x |
| 2015-12-31 | $22.34 | $294.73 | x |
| 2016-12-31 | $25.23 | $294.73 | x |
| 2017-12-31 | $26.29 | $294.73 | x |
| 2018-12-31 | $30.84 | $294.73 | x |
| 2019-12-31 | $33.71 | $294.73 | x |
| 2020-12-31 | $34.40 | $294.73 | x |
| 2021-12-31 | $38.91 | $294.73 | x |
| 2022-12-31 | $43.47 | $294.73 | x |
| 2023-12-31 | $48.46 | $294.73 | x |
| 2024-12-31 | $53.51 | $294.73 | x |
| 2025-12-31 | $58.66 | $294.73 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Stryker Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 14.48%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 12.92%
- • Asset Turnover: 0.52x
- • Equity Multiplier: 2.13x
- Recent ROE (14.48%) is below the historical average (17.13%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1985 | 17.32% | 8.27% | 1.44x | 1.46x | $3.55 Million |
| 1986 | 16.92% | 8.34% | 1.41x | 1.44x | $4.13 Million |
| 1987 | 16.89% | 8.58% | 1.41x | 1.40x | $5.18 Million |
| 1988 | 17.47% | 8.90% | 1.43x | 1.37x | $6.80 Million |
| 1989 | 17.14% | 8.50% | 1.48x | 1.36x | $8.00 Million |
| 1990 | 15.96% | 8.41% | 1.34x | 1.42x | $8.81 Million |
| 1991 | 18.40% | 9.07% | 1.35x | 1.50x | $15.11 Million |
| 1992 | 20.53% | 10.00% | 1.40x | 1.46x | $24.47 Million |
| 1993 | 20.87% | 10.80% | 1.23x | 1.57x | $31.36 Million |
| 1994 | 20.21% | 10.62% | 0.89x | 2.14x | $36.57 Million |
| 1995 | 19.15% | 9.98% | 1.02x | 1.88x | $41.57 Million |
| 1996 | 19.70% | 11.48% | 0.92x | 1.87x | $51.46 Million |
| 1997 | 20.45% | 12.78% | 0.99x | 1.61x | $64.02 Million |
| 1998 | 6.07% | 3.59% | 0.38x | 4.43x | $-25.61 Million |
| 1999 | 2.89% | 0.92% | 0.82x | 3.84x | $-47.75 Million |
| 2000 | 25.85% | 9.65% | 0.94x | 2.84x | $135.51 Million |
| 2001 | 25.28% | 10.26% | 1.07x | 2.29x | $161.38 Million |
| 2002 | 23.07% | 11.48% | 1.07x | 1.88x | $195.78 Million |
| 2003 | 21.05% | 12.51% | 1.15x | 1.47x | $238.02 Million |
| 2004 | 16.92% | 10.93% | 1.04x | 1.48x | $190.50 Million |
| 2005 | 20.46% | 13.86% | 0.99x | 1.50x | $345.18 Million |
| 2006 | 18.56% | 14.39% | 0.92x | 1.40x | $358.60 Million |
| 2007 | 18.92% | 16.96% | 0.82x | 1.37x | $479.55 Million |
| 2008 | 21.23% | 17.08% | 0.88x | 1.41x | $607.13 Million |
| 2009 | 16.79% | 16.47% | 0.74x | 1.38x | $447.89 Million |
| 2010 | 17.75% | 17.40% | 0.67x | 1.52x | $556.04 Million |
| 2011 | 17.51% | 16.19% | 0.67x | 1.61x | $576.70 Million |
| 2012 | 15.10% | 14.99% | 0.64x | 1.57x | $438.30 Million |
| 2013 | 11.12% | 11.15% | 0.57x | 1.74x | $101.30 Million |
| 2014 | 5.99% | 5.32% | 0.55x | 2.06x | $-344.60 Million |
| 2015 | 16.91% | 14.47% | 0.61x | 1.91x | $587.90 Million |
| 2016 | 17.25% | 14.54% | 0.55x | 2.14x | $692.00 Million |
| 2017 | 10.21% | 8.20% | 0.56x | 2.22x | $20.60 Million |
| 2018 | 30.29% | 26.12% | 0.50x | 2.32x | $2.38 Billion |
| 2019 | 16.26% | 13.99% | 0.49x | 2.36x | $802.30 Million |
| 2020 | 12.22% | 11.14% | 0.42x | 2.62x | $290.60 Million |
| 2021 | 13.40% | 11.66% | 0.49x | 2.33x | $506.30 Million |
| 2022 | 14.19% | 12.78% | 0.50x | 2.22x | $696.40 Million |
| 2023 | 17.02% | 15.44% | 0.51x | 2.15x | $1.31 Billion |
| 2024 | 14.51% | 13.25% | 0.53x | 2.08x | $929.60 Million |
| 2025 | 14.48% | 12.92% | 0.52x | 2.13x | $1.00 Billion |
Industry Comparison
This section compares Stryker Corporation's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $2,555,245,291
- Average return on equity (ROE) among peers: -57.95%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Stryker Corporation (SYK) | $22.42 Billion | 17.32% | 1.13x | $112.79 Billion |
| Abbott Laboratories (ABT) | $24.08 Billion | 18.37% | 0.83x | $155.56 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-95.88 Million | 0.00% | 0.00x | $21.60 Million |
| Aethlon Medical Inc (AEMD) | $9.29 Million | -84.45% | 0.15x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $105.73 Million | -116.68% | 0.61x | $903.35K |
| Adapthealth Corp (AHCO) | $1.47 Billion | -46.29% | 2.07x | $1.39 Billion |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $15.99 Million |
| Allurion Technologies, Inc. (ALUR) | $-70.49 Million | 0.00% | 0.00x | $8.10 Million |
| Autonomix Medical, Inc. Common Stock (AMIX) | $644.00K | -309.01% | 0.34x | $4.22 Million |
| Artivion Inc (AORT) | $30.20 Million | 15.56% | 0.78x | $1.73 Billion |
| Apyx Medical Inc (APYX) | $22.89 Million | 2.69% | 0.23x | $125.55 Million |
About Stryker Corporation
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment … Read more